drugset / Trial / NCT04441788
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the effect of ION-827359 on forced expiratory volume in 1 second (FEV1) in participants with mild to moderate COPD with CB.
Timeline
- Start
- 2020-12-22
- Primary completion
- 2021-04-27
- Completion
- 2021-08-09
Outcome
Outcome not reported
Stopped (Business): “Business Decision to Terminate Study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COFIRASERSEN | Unknown | 37.5 mg | Inhaled |
| Subject | COFIRASERSEN | Unknown | 75 mg | Inhaled |